The underreporting of hepatocellular carcinoma to the cancer register and a log-linear model to estimate a more correct incidence

Hepatology

Volumn 65, Issue 3, 2017, Pages 885-892

  Törner, Anna ^a   Stokkeland, Knut ^a,b   Svensson, Åke ^c   Dickman, Paul W ^a   Hultcrantz, Rolf ^a   Montgomery, Scott ^a,d,e   Duberg, Ann Sofi ^d  

^a KAROLINSKA INSTITUTE   (Sweden)

^b Visby Hospital   (Sweden)

^c STOCKHOLM UNIVERSITY   (Sweden)

^d ÖREBRO UNIVERSITY   (Sweden)

^e UNIVERSITY COLLEGE LONDON   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BILE DUCT CARCINOMA; CANCER DIAGNOSIS; CANCER INCIDENCE; CANCER REGISTRY; CAUSE OF DEATH; CONTROLLED STUDY; FEMALE; HEPATITIS C; HUMAN; ICD-8; ICD-9; LIVER CANCER; LIVER CELL CARCINOMA; LOGLINEAR MODEL; MAJOR CLINICAL STUDY; MALE; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; NEEDS ASSESSMENT; PREVALENCE; REGISTER; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SWEDEN;

CARCINOMA, HEPATOCELLULAR; FEMALE; HUMANS; LIVER NEOPLASMS; MALE; NEEDS ASSESSMENT; PREVALENCE; REGISTRIES; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SWEDEN;

EID: 84994719196     PISSN: 02709139     EISSN: 15273350     Source Type: Journal    
DOI: 10.1002/hep.28775     Document Type: Article

References (19)

1. World Health Organization. GLOBOCAN 2012: estimated cancer incidence, mortality and prevalence worldwide in 2012. http://globocan.iarc.fr/Pages/fact_sheets_population.aspx. Accessed March 2, 2016.
2. El-Serag HB. Hepatocellular carcinoma. N Engl J Med 2011;365:1118–1127.
3. Duberg AS, Blach S, Falconer K, Kåberg M, Razavi H, Aleman S. The future disease burden of hepatitis C virus infection in Sweden and the impact of different treatment strategies. Scand J Gastroenterol 2015;50:233–244.
4. Socialstyrelsen. Cancer incidence in Sweden 2010. http://www.socialstyrelsen.se/Lists/Artikelkatalog/Attachments/18530/2011-12-15.pdf. Accessed March 2, 2016.
5. Barlow L, Westergren K, Holmberg L, Talbäck M. The completeness of the Swedish Cancer Register: a sample survey for year 1998. Acta Oncol 2009;48:27–33.
6. European Association for the Study of the Liver, European Organisation for Research and Treatment of Cancer. EASL-EORTC clinical practice guidelines: management of hepatocellular carcinoma. J Hepatol 2012;56:908–943.
7. Kaczynski J, Hansson G, Wallerstedt S. Clinical features in hepatocellular carcinoma and the impact of autopsy on diagnosis. A study of 530 cases from a low-endemicity area. Hepatogastroenterology 2005;52:1798–1802.
8. Socialstyrelsen. The National Board of Health and Welfare. http://www.socialstyrelsen.se/english. Accessed March 2, 2016.
9. Folkhälsomyndigheten. Public Health Agency of Sweden, Homepage, Hepatitis C statistics. http://www.folkhalsomyndigheten.se/amnesomraden/statistik-och-undersokningar/sjukdomsstatistik/hepatit-c/. Accessed March 2, 2016.
10. Ludvigsson JF, Andersson E, Ekbom A, Feychting M, Kim JL, Reuterwall C, et al. External review and validation of the Swedish national inpatient register. BMC Public Health 2011;11:450.
11. Duberg A, Janzon R, Bäck E, Ekdahl K, Blaxhult A. The epidemiology of hepatitis C virus infection in Sweden. Euro Surveill 2008;13(21).
12. Strauss R, Torner A, Duberg AS, Hultcrantz R, Ekdahl K. Hepatocellular carcinoma and other primary liver cancers in hepatitis C patients in Sweden—a low endemic country. J Viral Hepat 2008;15:531–537.
13. McClish D, Penberthy L. Using Medicare data to estimate the number of cases missed by a cancer registry: a 3-source capture-recapture model. Med Care 2004;42:1111–1116.
14. Kilander C, Mattsson F, Ljung R, Lagergren J, Sadr-Azodi O. Systematic underreporting of the population-based incidence of pancreatic and biliary tract cancers. Acta Oncol 2014;53:822–829.
15. Lambe M, Eloranta S, Wigertz A, Blomqvist P. Pancreatic cancer; reporting and long-term survival in Sweden. Acta Oncol 2011;50:1220–1227.
16. Luo J, Adami HO, Reilly M, Ekbom A, Nordenvall C, Ye W. Interpreting trends of pancreatic cancer incidence and mortality: a nation-wide study in Sweden (1960-2003). Cancer Causes Control 2008;19:89–96.
17. Ji J, Sundquist K, Sundquist J, Hemminki K. Comparability of cancer identification among Death Registry, Cancer Registry and Hospital Discharge Registry. Int J Cancer 2012;131:2085–2093.
18. Hong T, Gow P, Fink M, Dev A, Roberts S, Nicoll A, et al. Novel population-based study finding higher than reported hepatocellular carcinoma incidence suggests an updated approach is needed. Hepatology 2016;63:1205–1212.
19. Bosetti C, Levi F, Boffetta P, Lucchini F, Negri E, La Vecchia C. Trends in mortality from hepatocellular carcinoma in Europe, 1980-2004. Hepatology 2008;48:137–145.